erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
. a senior northern ireland civil servant has apologised after hundreds of neurology patients were recalled for further testing.
.
.
.